Abstract
The purine analogue, 8-azaguanine, inhibits the induction of uterine glucose-6-P dehydrogenase (D-glucose-6-phosphate: NADP+ oxidoreductase, EC 1.1.1.49) by estradiol or the enzyme's co-factor, NADP+. Inactivation of the enzyme after estradiol withdrawal was not affected by 8-azaguanine treatment. Since 8-aza-guanine limited the uterine response to estradiol when injected at any time after the steroid, the RNA necessary for the synthesis of uterine glucose-6-P dehydrogenase must be synthesized continuously after the initiation of the uterine response to estradiol.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
